ARTICLE | Company News
Abilita deal
February 3, 2017 9:20 PM UTC
Abilita partnered with an undisclosed pharmaceutical company to use its EMP membrane protein evolution platform to discover and develop proteins that target GPCRs. Abilita will receive an upfront paym...
BCIQ Company Profiles